📌 Existing Clients Scaling Up
🔹 CaratLane: Plans to open 300+ new stores
🔹 Malabar Gold: Expanding at 100+ stores/year
#SkyGold
5/10
📊 Financial Strength – Credit Rating & Fund Raising
📌 Credit Rating Upgrade
🔹 India Ratings upgraded bank loans to IND A-/Stable
📌 Recent Fundraising (QIP)
🔹 ₹270 Cr raised via Qualified Institutional Placement (QIP) at ₹2,692/share
🔹 Investors: Motilal Oswal Fund, Kotak Mahindra Life, Bank of India Fund
#SkyGold
📌 Future Acquisition Plans
🔹 Pursuing more inorganic growth opportunities to reinforce market position
#SkyGold
7/10
📌 Leadership Update
📌 New Independent Director Appointment
🔹 Mr. Bharat Jhaveri joins as Independent Director
🔹 Expertise in Gemology & Diamond Assortment
🔹 Led key projects for Tanishq & introduced Open Polki jewelry
#SkyGold
Sky Gold Limited is set for exponential growth in the coming years! 💎📈
📢 Disclosure: This is NOT a Buy/Sell/Hold recommendation. Shared for educational purpose only. Please do your own due diligence.
#SkyGold
10/10
🥇Here are some excellent X accounts sharing valuable stock market investing content.
🎯Think this thread could help other investors?💭Kindly Share the first post!
🔹Defence electronics leader specializing in electronic, electromechanical, and engineering design, offering end-to-end solutions in Aerospace, Defense, Space & Homeland Security through design, manufacturing, and testing.
🔹With strong financials, a growing order book, and expansion plans, AMS is targeting 45-50% annual growth, aiming to 2X revenues in 2 years.
🔹Acquires 100% stake in IDL Explosives (Hinduja Group) for ₹107 Cr
📌 Apollo Micro Systems transitions from a weapon electronics company to a complete weapons system supplier, unlocking value across the full lifecycle from arming electronics to final munitions platforms.
💼 Apollo Micro Systems | IDL Explosives : Investor Presentation
🔹Acquires 100% stake in IDL Explosives (Hinduja Group) for ₹107 Cr in an all-cash deal.
🛸 Vertical Integration
🔹Combines Apollo’s electronics & weapon platform design with IDL’s energetics & explosives
🔹 Creates a full-spectrum, Tier-I OEM offering across munitions & integrated systems
🔹Unlocks cost-efficiencies via in-house manufacturing, IP control and bulk procurement
🌎 Geographic & Product Expansion
🔹Enters East/West Africa, Middle East, SE Asia, Far East
🔹CE-certified products enable European market access
🔹New product classes: artillery shells, loitering munitions, torpedoes, UAV payloads
📌 Increased Tender Eligibility: Apollo can now participate in larger and more complex defence contracts needing indigenous solutions
🌎Global-Domestic Market Opportunity
🔹Global explosives market expected to grow to $9.37B by 2029 (CAGR: 8.8%)
🔹India’s defence exports hit ₹23,622 Cr in FY25
📌 Key trigger: Global conflicts (Europe, West Asia) + Atmanirbhar Bharat push
💼 Product Portfolio | Existing + Integrated
🔹 Underwater mines & moored mines
🔹 Medium-range aerial rockets 🚀
🔹 Limpet mines, aerial bombs 💣
🔹 ESAD fuze, warheads for UAV-launched PGMs
🔹 DRDO Technology Transfer received for critical munitions components
💡 Apollo Micro Systems transitions from a weapon electronics company to a complete weapons system supplier, unlocking value across the full lifecycle from arming electronics to final munitions platforms.
🔹Founded: 1985
🔹HQ: Hyderabad, India
🔹Business: Defense Electronics & Aerospace Solutions
🔹Presence: Pan-India + Expanding Global Ties
🔹Manufacturing: Unit I - 55,000 sq. ft. (IDA Mallapur) | Unit II - 40,000 sq. ft. (Adibatla) (Q1FY26) | Unit III (Upcoming) - 3,50,000 sq. ft. IPiDS (Hardware Park-II) (Q2FY26)
🔹Order Book: ₹500-550 Cr → Targeting ₹2,500 Cr+ by Dec 2026
🔹Market Position: Key supplier for Missile Systems, Naval Torpedoes & Avionics
🔹Production Utilization: Expanding to support 45-50% annual growth
🔹R&D Spend: 7-8% of revenue on cutting-edge defense tech
🔹Subsidiaries:
1️⃣ Ananya SIP RF Technologies - RF & Microwave Systems
2️⃣ Apollo Defence Industries (ADIPL) - Expanding Defense Manufacturing
3️⃣ Apollo Strategic Technologies
🔹Backward integrated 🌎 EPC Powerhouse specializing in Power T&D, Railways, Civil Infra & Lighting - operates in 58 countries.
🔹 ~ ₹15000 Cr Order Book as on end of Q4FY25 | 90% Power T&D | 49% Domestic, 51% International
🔹 1,42,000 MTPA Capacity & ~1,62,000+ MTPA Post-expansion (FY26)
🔹Leading player in 800kV HVDC projects & Urban Infra
#Transrail #StocksToWatch #StocksInFocus
2/10
💼 Managing Director and CEO, Randeep Narang, revealed that total orders for Q4FY25 stand at around ₹4000 crore, with the company projecting 28-30% revenue growth for FY25.
⚡️ Overall order book: ~₹15,000 Cr as on end of Q4FY25.
Poly Medicure 📊📚🧵 - Leader in medical devices space
🥇 Indian Medical Devices Leader of the Year Award 2022 by GOI.
🔹 India’s medical device market is set to triple from $11B → $30B in 5 years
🔹India's top medical device exporter for 10+ years
🔹12 manufacturing facilities and an R&D center, producing ~1.8B devices annually.
🔹200+ devices in its portfolio and clients in 125+ countries
🔹~350 patents with 44 more pending globally.
#Polymed #Polymedicure #MedicalDevice
2/8
🏥 Direct from the management
🎥 Himanshu Baid - MD, Poly Medicure on CNBCTV18
🔹Guiding for 20%+ revenue growth for the next 2-3 years
🔹Margin will improve 100-120 bps on a full year basis
🔹India continues to remain an important market, growing at 50%.
🔹One of the largest & major global PepsiCo franchisees, producing and distributing both carbonated (Pepsi, 7up, Mirenda, Mountain Dew) and non-carbonated beverages (Tropicana, Aquafina).
🔹Operating in 27 Indian states and 7 UTs, VBL also serves markets in Nepal, Sri Lanka, Africa 🌍 and more.
🔹10X Returns in last 5 years.
🔹Massive profit growth of ~42% CAGR over last 5 years.
📊Data Credit: Sovrenn and Company Reports
#VarunBeverages #VBL #Q4FY25
2 | ❄️Key Developments
🔹Varun Beverages moves closer to acquiring SBC Beverages Ghana & Tanzania pending final approvals.
🔹Commenced production at a new plant in Kinshasa, DRC (Congo, Africa), with two PET lines for carbonated soft drinks and packaged water, each with a capacity of 550 BPM (bottles per minute).
🔹VBL has partnered with PepsiCo's Premier Nutrition Trading LLC to produce and distribute "Simba Munchiez" in Zimbabwe and Zambia. A USD 7 million investment is planned for facilities, with operations set to begin by October 2025 in Zimbabwe and April 2026 in Zambia.
🔹Expanding production capacity in Rajasthan & MP.
🔹Started commercial production of Carbonated Soft Drinks, Juices, Beverages Base Syrup & PET Preform at its production facility at Khordha, Odisha and PET Preform & Closures at its production facility at Guwahati, Assam.
🏢 Recently announced the manufacturing of Cheetos in Morocco by May 2025.
🏏 Higher demand for cold beverages & snacks due to its strong brand association with ongoing IPL.
#VarunBeverages #VBL #Q4FY25
3 |❄️Varun Beverages Q3FY24 Results (YoY):
🔹Revenue 📈 39.8% at ₹3,818 Cr vs ₹2,731 Cr
🔹Net Profit 📈 40.2% at ₹185 Cr vs ₹132 Cr
🔹EBITDA 📈 38.8% at ₹580 Cr vs ₹418 Cr
🔹EBITDA Margin 14% vs 15%
Key Takeaways:
🔹Strong revenue and profit growth, driven by higher demand.
🔹EBITDA growth aligns with revenue expansion.
🔹Margin is flat, possibly due to input cost pressures.
Distinct Specialty & Complex Product Portfolio
🔹Revenue Guidance: ₹4.2B in FY25 & ₹7B in FY26
🔹ANDA filings: 14 products for institutional supply (govt)
🔹US tariff impact: Possible benefit, but too early to assess
CDMO & Pipeline
🔹Semaglutide filed (Oral & Injectables)
🔹RFQ for CDMO bookings: 80%
🔹Injectables plant in USA with ₹1B investment
Market Positioning
🔹US plant utilization to reach ~65-70% by FY26
🔹Targeting unmet needs in emerging markets
🔹TAM for ANDA portfolio: $421M (IQVIA) & $1.3B (Symphony)
🥇 Strong pipeline, strategic global expansion & focused CDMO play make Senores a key pharma player to watch.
Source : Centrum
#Senores #SenoresPharma #CDMO
3/12
🏢 Subsidiaries & Business Divisions:
🔹Senores Pharmaceuticals Inc. (100% Subsidiary) – ANDA holding company for US operations
🔹Havix Group Inc. (66.58% Subsidiary) – CDMO & Generic Formulations for US & Canada
🔹Ratnatris Pharmaceuticals Pvt. Ltd. (69% Subsidiary) – Manufacturing & marketing in emerging markets
🥇With a robust product pipeline, CDMO expansion, and strong regulatory market presence, Senores Pharma is set for explosive growth.
1️⃣ Regulated Market Pharma Business -Developing & manufacturing niche pharmaceutical formulations for US, Canada, and UK markets.
2️⃣ Emerging Market Pharma Business - Expanding presence in 40+ countries with a growing portfolio of specialty generics.
3️⃣ Contract Development & Manufacturing (CDMO/CMO) - Customized formulation, development & manufacturing for global pharma companies.
4️⃣ Critical Care Injectables & API Manufacturing - Backward integration for cost efficiency & supply chain control.
🌡️ Product Portfolio & Business Verticals:
🔹Regulated Markets (US, Canada, UK):
1️⃣ Branded Generics & Complex Formulations - Own & partnered ANDAs (22 commercialized, 24 approved, 51 in pipeline).
2️⃣ Competitive Generic Therapy (CGT) Products - 28 pipeline CGT opportunity molecules.
3️⃣ CDMO/CMO Partnerships - Providing end-to-end drug development, formulation & contract manufacturing services to global pharma giants.
🔹Emerging Markets (40+ countries):
1️⃣ Diverse Portfolio – 267 registered products across CNS, Cardiovascular, Pain Management & Anti-infectives.
2️⃣ Multiple Market Models – Distributor partnerships, own branded generics, & licensing agreements.
🔹API & Injectable Business:
1️⃣ API Manufacturing – Producing critical APIs for regulated & emerging markets.
2️⃣ Critical Care Injectables – Direct hospital supplies via multi-specialty chains (55 products launched).
🥇 Senores is a fully integrated pharmaceutical player, leveraging its strong R&D, CDMO expansion, and global market presence for exponential growth
🏗️KRN is a leading manufacturer of fin and tube-type heat exchangers for the HVAC&R industry.
🏗️With strong financials, aggressive expansion & rising exports, KRN is set for 5x-6x growth in 3 years.
🔹Presence: Pan-India + Expanding Exports 🌍
🔹Manufacturing Plants: 2 facilities in Neemrana, Rajasthan
🔹Total Production Capacity: 1 billion units annually
🔹Market Position: Leading Indian HVAC & Refrigeration Component Supplier
🔹Utilization: 84% of Production Capacity
🥇 With rising demand for energy-efficient cooling solutions, KRN is poised for raid growth!